|
CYB5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.62180000001988E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.50630000000418E-05 |
| Normal-vs-Stage2 |
4.934200E-02 |
| Normal-vs-Stage3 |
3.803500E-02 |
| Normal-vs-Stage4 |
5.001800E-01 |
| Stage1-vs-Stage2 |
5.735000E-01 |
| Stage1-vs-Stage3 |
9.585800E-01 |
| Stage1-vs-Stage4 |
2.417400E-01 |
| Stage2-vs-Stage3 |
6.501800E-01 |
| Stage2-vs-Stage4 |
3.755200E-01 |
| Stage3-vs-Stage4 |
3.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.37470000000284E-06 |
| Normal-vs-AfricanAmerican |
6.257600E-03 |
| Normal-vs-Asian |
3.639000E-01 |
| Caucasian-vs-AfricanAmerican |
8.053700E-02 |
| Caucasian-vs-Asian |
8.541000E-01 |
| AfricanAmerican-vs-Asian |
6.994400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58552999999229E-05 |
| Normal-vs-Female |
1.198180E-03 |
| Male-vs-Female |
9.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.871700E-02 |
| Normal-vs-Extreme_Weight |
3.610100E-04 |
| Normal-vs-Obese |
1.440990E-04 |
| Normal-vs-Extreme_Obese |
3.569000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.230200E-01 |
| Normal_Weight-vs-Obese |
1.201350E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.746600E-01 |
| Extreme_Weight-vs-Obese |
7.023200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.084800E-01 |
| Obese-vs-Extreme_Obese |
4.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.051570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.70632999999532E-05 |
| Normal-vs-Age(61-80Yrs) |
1.014620E-04 |
| Normal-vs-Age(81-100Yrs) |
6.492400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.851000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.022800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.316400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.836800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.715900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.497250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.36120000218776E-08 |
| Normal-VS-Type2 PRCC |
1.621210E-01 |
| Normal-VS-KIRP CIMP |
2.296100E-02 |
| Normal-VS-Unclassified PRCC |
1.164150E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.248400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.856400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.282000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.937800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.323440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.082800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.248360E-01 |
| Normal-vs-N1 |
3.728000E-02 |
| Normal-vs-N2 |
2.307000E-01 |
| N0-vs-N1 |
7.244800E-01 |
| N0-vs-N2 |
2.632400E-01 |
| N1-vs-N2 |
7.724200E-02 |
|
|
